Distributing opioid overdose reversal medications (2SSB 5195)

2SSB 5195 helps to increase access to naloxone for all individuals at risk of an opioid overdose. The law requires hospital emergency departments (EDs) and many certified and licensed behavioral health settings to distribute prepackaged naloxone to individuals at risk of an opioid overdose.

Behavioral health agencies

Education materials

Please reference appendices J & K in the toolkits to locate translated versions of these educational materials.


Emergency department (ED)

ED toolkit

ED appendices 

Behavioral health agency (BHA)

BHA Toolkit

BHA appendices


Billing resources


For Medicaid billing and pharmacy questions
Email: Applehealthpharmacypolicy@hca.wa.gov

For assistance on billing for opioid reversal medication for uninsured clients
Email: HCANaloxoneReimbursement@hca.wa.gov

For training, consultation, educational materials, and implementation questions
Laura Meader, MA, LICSW
Overdose reversal medication program director
Email: laura.meader@hca.wa.gov